More Patients and Medical Articles

Patients and Medical

AstraZeneca: An Embarrassment Of Riches

Hugh Gosling, (Feb 7, 2018)

Medical Affairs has seen unprecedented growth in both size and scope in recent years, so new skills and capabilities are needed, says AZ’s Mark Mallon
Patients and Medical

Clinical Trial Diversity: Vive La Différence

Hugh Gosling, (Jan 24, 2018)

Many companies are working hard to ensure their clinical trial populations match the diversity of the intended patient population, and Medical has a central role to play.
Patients and Medical

Medical Under The Microscope

Danielle Barron, (Jan 5, 2018)

Nestlé Health Science's Chief Medical Officer presents the pluses of applying a more scientific approach to medical
Patients and Medical

Carers: The Forgotten Heroes of Healthcare

Hugh Gosling, (Dec 19, 2017)

A new campaign to raise awareness of the needs of care-givers is paving the way for pharma to not just go beyond the pill but also beyond the patient
Patients and Medical

Latin America: The Growing Pains Of Patient-Centricity

Adam Hill, (Dec 6, 2017)

US and European markets are steering the ship on patient-centricity. But where is Latin America in this space?
Patients and Medical

Medical Meets Machine

Danielle Barron, (Nov 15, 2017)

Pharma needs to be at the intersection between technological innovation and medical insight
Patients and Medical

Digging For Gold

Lucy Fulford, (Nov 1, 2017)

As Medical gets more involved in real-world evidence, what challenges does it face in proving the value of a medicine?
Patients and Medical

MSLs: The Superheroes of Pharma?

Lucy Fulford, (Oct 25, 2017)

MSLs are pharma’s elite, with the knowledge and interpersonal skills to engage and collaborate with customers. But is pharma asking too much of its scientific superheroes?
Patients and Medical

Patient-Centricity: Cracking The Formula

Adam Chapman, (Oct 19, 2017)

Novartis Spain’s Cesar Concepcion is on a mission to champion the patient
Patients and Medical

Redefining Medical Need

Lucy Fulford, (Sep 15, 2017)

To truly understand unmet medical need, we need to stop focusing on the disease and start talking to patients, says Allergan CMO, Gavin Corcoran

Pages